• About Dr. Martin D’Agostino
  • Training Course
  • Student Rates Training
  • Virus News
    • Norovirus Latest News
    • Hepatitis A virus Latest News
    • Hepatitis E virus Latest News
  • FAQ
  • Foodborne Viruses
    • Norovirus and Food Safety
    • Hepatitis A virus and Food Safety
    • Hepatitis E Virus and Food Safety
ViroSafety LTD
  • About Dr. Martin D’Agostino
  • Training Course
  • Student Rates Training
  • Virus News
    • Norovirus Latest News
    • Hepatitis A virus Latest News
    • Hepatitis E virus Latest News
  • FAQ
  • Foodborne Viruses
    • Norovirus and Food Safety
    • Hepatitis A virus and Food Safety
    • Hepatitis E Virus and Food Safety

© 2026 ViroSafety LTD

  • About Dr. Martin D’Agostino
  • Training Course
  • Student Rates Training
  • Virus News
    • Norovirus Latest News
    • Hepatitis A virus Latest News
    • Hepatitis E virus Latest News
  • FAQ
  • Foodborne Viruses
    • Norovirus and Food Safety
    • Hepatitis A virus and Food Safety
    • Hepatitis E Virus and Food Safety
ViroSafety LTD
  • About Dr. Martin D’Agostino
  • Training Course
  • Student Rates Training
  • Virus News
    • Norovirus Latest News
    • Hepatitis A virus Latest News
    • Hepatitis E virus Latest News
  • FAQ
  • Foodborne Viruses
    • Norovirus and Food Safety
    • Hepatitis A virus and Food Safety
    • Hepatitis E Virus and Food Safety

© 2026 ViroSafety LTD

  • [Press release] Atea Pharmaceuticals initiates first-in-human Phase 1 clinical trial of AT-587 for the treatment of hepatitis
    26 July 2026
    AT-587 is a proprietary oral antiviral nucleotide analog being developed for the treatment of HEV.
  • Limited hepatitis E knowledge in pig sector hinders assessment approach
    22 July 2026
    Current hepatitis E virus knowledge in Ireland is limited, creating uncertainty in assessing the risk related to the consumption of pork products. Despite the lack of information, the Food Safety Authority of Ireland (FSAI) said the available data supports the hypothesis that the pig meat food chain contributes to the
  • Global Viral Hepatitis
    21 July 2026
    World Hepatitis Day is July 28th—see how viral hepatitis impacts millions and what CDC is doing.
  • Atea Pharma presents data on compounds for hepatitis E
    14 July 2026
    Atea Pharmaceuticals Inc. recently presented preclinical data on two of its compounds, AT-2490 and AT-587, which have shown promising antiviral potential for treating hepatitis E virus infection.
  • Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis
    14 July 2026
    Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers
  • Atea begins phase 1 trial of hepatitis
    14 July 2026
    Atea begins phase 1 trial of hepatitis E treatment AT-587
  • Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis
    14 July 2026
    Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers AT-587 is a Potential First-in Class…
  • Hepatitis E Has No Approved Treatments as Atea Begins Human Trial
    14 July 2026
    AT-587 was 30- to 150-fold more potent in vitro than sofosbuvir and ribavirin; its Phase 1 study will assess safety, tolerability and pharmacokinetics.
  • Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis
    14 July 2026
    Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers AT-587 is a Potential First-in Class Treatment for Hepatitis E Virus, a Serious Liver Disease with No Approved Therapies Study Initiation Represents an Important Milestone Advancing Atea’s Antiviral Pipeline Focusing on First- or Best-in-Class Product Candidates in Areas of […]
  • Centre for Health Protection Investigates Human Infection of Rat Hepatitis
    13 July 2026
    CHP investigates a case of human infection of rat Hepatitis E virusThe Centre for Health Protection
  • CHP Investigates Human Infection of Rat Hepatitis
    13 July 2026
    CHP investigates a case of human infection of rat Hepatitis E virusThe Centre for Health Protection
  • Early Hepatitis
    13 July 2026
    Discover how Hepatitis E viruses dynamically mutate during early acute infection, using transcomplementation to survive and adapt within the host.
  • Hepatitis es mutate early during infection
    13 July 2026
    Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability. Researchers from the Ruhr University Bochum Departments of Molecular & Medical Virology and Translational & Computational Infection Research, Germany, have taken a closer look at the early phase of hepatitis E infections. To do this, they worked […]
  • New study tracks early genetic changes in hepatitis
    13 July 2026
    Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability.
  • Hepatitis es mutate early during infection
    13 July 2026
    Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability. Researchers from the Departments of Molecular & Medical Virology and Translational …
  • Frontiers | Case Report: Allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and hepatitis E
    1 July 2026
    In immunocompromised patients the Hepatitis E Virus (HEV) can lead to severe liver injury and possible liver failure. This case report describes a patient wi…
  • What's DAFM's 'total landholding'?
    27 June 2026
    Find out what DAFM's landholding is in your county
  • Hepatitis genes found in pigmeat products
    27 June 2026
    Hepatitis E virus genes have been identified in pigmeat products in several countries, including Ireland, according to the FSAI
  • Hepatitis E
    26 June 2026
    WHO fact sheet on hepatitis E, how it is transmitted, symptoms, prevention, testing and diagnosis, treatment and WHO activities.
  • Hepatitis B
    10 June 2026
    Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. This fact sheet provides information about transmission, symptoms, diagnosis, treatment, prevention and WHO's work to support prevention and treatment.

© 2026 ViroSafety LTD.